1. Home
  2. JAGX vs CHEK Comparison

JAGX vs CHEK Comparison

Compare JAGX & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • CHEK
  • Stock Information
  • Founded
  • JAGX 2013
  • CHEK 2004
  • Country
  • JAGX United States
  • CHEK Israel
  • Employees
  • JAGX N/A
  • CHEK N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • JAGX Health Care
  • CHEK Health Care
  • Exchange
  • JAGX Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • JAGX 8.1M
  • CHEK 4.0M
  • IPO Year
  • JAGX N/A
  • CHEK 2015
  • Fundamental
  • Price
  • JAGX $8.51
  • CHEK $0.82
  • Analyst Decision
  • JAGX
  • CHEK
  • Analyst Count
  • JAGX 0
  • CHEK 0
  • Target Price
  • JAGX N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • JAGX 246.2K
  • CHEK 75.3K
  • Earning Date
  • JAGX 05-16-2025
  • CHEK 05-20-2025
  • Dividend Yield
  • JAGX N/A
  • CHEK N/A
  • EPS Growth
  • JAGX N/A
  • CHEK N/A
  • EPS
  • JAGX N/A
  • CHEK N/A
  • Revenue
  • JAGX $11,689,000.00
  • CHEK N/A
  • Revenue This Year
  • JAGX $38.22
  • CHEK N/A
  • Revenue Next Year
  • JAGX $39.96
  • CHEK N/A
  • P/E Ratio
  • JAGX N/A
  • CHEK N/A
  • Revenue Growth
  • JAGX 19.75
  • CHEK N/A
  • 52 Week Low
  • JAGX $4.02
  • CHEK $0.56
  • 52 Week High
  • JAGX $502.50
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.54
  • CHEK 52.03
  • Support Level
  • JAGX $10.41
  • CHEK $0.73
  • Resistance Level
  • JAGX $13.20
  • CHEK $1.11
  • Average True Range (ATR)
  • JAGX 1.90
  • CHEK 0.11
  • MACD
  • JAGX 0.07
  • CHEK 0.02
  • Stochastic Oscillator
  • JAGX 29.02
  • CHEK 38.54

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: